Cita APA (7a ed.)
Bors, A., Kozma, A., Tomán, Á., Őrfi, Z., Kondor, N., Tasnády, S., . . . Andrikovics, H. (2024). IGH: :NSD2 Fusion Gene Transcript as Measurable Residual Disease Marker in Multiple Myeloma. Cancers, 16(2), 283-295.
Cita Chicago Style (17a ed.)
Bors, András, et al. "IGH: :NSD2 Fusion Gene Transcript as Measurable Residual Disease Marker in Multiple Myeloma." Cancers 16, no. 2 (2024): 283-295.
Cita MLA (9a ed.)
Bors, András, et al. "IGH: :NSD2 Fusion Gene Transcript as Measurable Residual Disease Marker in Multiple Myeloma." Cancers, vol. 16, no. 2, 2024, pp. 283-295.
Precaución: Estas citas no son 100% exactas.